About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Parcel Pickup

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Karyopharm Therapeutics Inc. - Common Stock (NQ:KPTI)

8.000 +0.650 (+8.84%)

Streaming Delayed Price Updated: 11:00 AM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Karyopharm Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

73 Biggest Movers From Yesterday ↗

February 23, 2022

Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) jumped 63.1% to close at $0.80 on Tuesday after declining around 7% on Friday. Indonesia Energy Corporation Limited (NYSE...

Via Benzinga

Why Are Karyopharm Shares Plunging Today? ↗

February 22, 2022

Karyopharm Therapeutics Inc (NASDAQ: KPTI) revealed that executive vice president and chief medical officer Jatin Shah departs for "other professional opportunities....

Via Benzinga

Where Karyopharm Therapeutics Stands With Analysts ↗

February 09, 2022

Karyopharm Therapeutics (NASDAQ:KPTI) has observed the following analyst ratings within the last quarter:

Via Benzinga

50 Stocks Moving In Tuesday's Mid-Day Session ↗

February 22, 2022

Gainers Indonesia Energy Corporation Limited (NYSE: INDO) jumped 75.2% to $7.87. Imperial Petroleum Inc. (NASDAQ: IMPP) rose 52.9% to $0.7500 after declining around 7% on Friday...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 22, 2022

Gainers Ocugen (NASDAQ:OCGN) stock rose 25.0% to $4.33 during Tuesday's regular session. As of 12:30 EST, Ocugen's stock is trading at a volume of 42.0 million,...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 22, 2022

Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 15.5% to $3.95 during Tuesday's pre-market session. The company's market cap stands at $213.3 million....

Via Benzinga

70 Biggest Movers From Friday ↗

February 22, 2022

Gainers Sky Harbour Group Corporation (NYSE: SKYH) shares jumped 48.4% to close at $10.09 on Friday. RISE Education Cayman Ltd (NASDAQ: REDU) gained 39.7% to settle at $0.95....

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 18, 2022

Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock moved upwards by 27.0% to $2.54 during Friday's regular session. The current volume of 40.0 million shares is 1123.6% of...

Via Benzinga

42 Stocks Moving In Friday's Mid-Day Session ↗

February 18, 2022

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 72.6% to $6.56 after jumping 17% on Thursday. Energy Vault Holdings, Inc. (NYSE: NRGV) climbed 40.5% to $15.60 after...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 9, 2022 ↗

February 09, 2022

Upgrades According to Capital One, the prior rating for Federal Realty Investment Trust (NYSE:FRT) was changed from Equal-Weight to Overweight. Federal Realty Investment...

Via Benzinga

51 Biggest Movers From Yesterday ↗

February 09, 2022

Also check out this: Apple And 3 Other Stocks Sold By Insiders Losers SelectQuote, Inc. (NYSE: SLQT) shares tumbled 47.3% to close at $3.44 on Tuesday after the company...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 08, 2022

Gainers Sundial Growers (NASDAQ:SNDL) sto...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 08, 2022

Gainers BioCardia (NASDAQ:BCDA) stock inc...

Via Benzinga

Karyopharm Shares Fall After Selinexor Data In Endometrial Cancer Patients ↗

February 08, 2022

Karyopharm Therapeutics Inc's (NASDAQ: KPTI) Phase 3 SIENDO selinexor study has

Via Benzinga

35 Stocks Moving In Tuesday's Mid-Day Session ↗

February 08, 2022

Gainers Society Pass Incorporated (NASDAQ: SOPA) gained 63.4% to $3.45 after dropping 16% on Monday. American Rebel Holdings, Inc. (NASDAQ: AREB) climbed 56.1% to $3.45 following...

Via Benzinga

Recap: Karyopharm Therapeutics Q4 Earnings ↗

February 08, 2022

Karyopharm Therapeutics (NASDAQ:KPTI) reported its Q4 earnings results on Tuesday, February 8, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar ↗

February 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 08, 2022

Gainers Second Sight Medical (NASDAQ:EYES) stock increased by 7.8% to $1.51 during Tuesday's pre-market session. The market value of their outstanding shares is at $59...

Via Benzinga

Karyopharm, Menarini Ink Over $200M Licensing Pact For Selinexor In Europe, Other Territories ↗

December 21, 2021

Karyopharm Therapeutics Inc (NASDAQ: KPTI) and the Menarini Group entered an exclusive licensing agreement whereby Menarini will commercialize Karyopharm's...

Via Benzinga

Cannabis Movers & Shakers: Coda Signature, Greater Cannabis Co., BioHarvest Sciences, Compass Pathways ↗

December 06, 2021

Coda Signature Taps Teddy C. Scott As Board Member Producer of cannabis-infused edibles and wellness products Coda Signature

Via Benzinga

Topics Cannabis

Karyopharm Therapeutics inc (KPTI) Q3 2021 Earnings Call Transcript ↗

November 03, 2021

KPTI earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Mid-Afternoon Market Update: Nasdaq Rises 60 Points; Federal Reserve Slows Down Bond Buying ↗

November 03, 2021

Toward the end of trading Wednesday, the Dow traded down 0.15% to 35,997.82 while the NASDAQ rose 0.38% to 15,709.60. The S&P also rose, gaining 0.13% to 4,636.89. The U.S....

Via Benzinga

Topics Economy Stocks

Earnings Scheduled For February 8, 2022 ↗

February 08, 2022

Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.

Via Benzinga

The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More ↗

December 06, 2021

The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 03, 2021

Gainers iRhythm Technologies (NASDAQ:IRTC) stock moved upwards by 52.78% to $117.34 during Wednesday's regular session. iRhythm Technologies's stock is trading at...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021 ↗

November 19, 2021

Upgrades Morgan Stanley upgraded the previous rating for EQT Corp (NYSE:

Via Benzinga

86 Biggest Movers From Yesterday ↗

November 04, 2021

Gainers FAT Brands Inc. (NASDAQ: FATBB) shares gained 99.2% to settle at $15.44. FAT Brands recently announced plans to acquire Fazoli’s Restaurant Chain for $130 million....

Via Benzinga

Mid-Day Market Update: Crude Oil Drops Over 3%; R.R.Donnelley & Sons Shares Jump ↗

November 03, 2021

Midway through trading Wednesday, the Dow traded down 0.21% to 35,978.38 while the NASDAQ rose 0.08% to 15,662.87. The S&P also fell, dropping 0.10% to 4,625.81. The U.S. has...

Via Benzinga

Topics Stocks

Karyopharm Therapeutics Earnings Perspective: Return On Capital Employed ↗

November 03, 2021

According to Benzinga Pro data, during Q3, Karyopharm Therapeutics (NASDAQ:KPTI) posted sales of $37.69 million. Earnings were up 10.68%, but Karyopharm Therapeutics still...

Via Benzinga

What 4 Analyst Ratings Have To Say About Karyopharm Therapeutics ↗

October 12, 2021

Analysts have provided the following ratings for Karyopharm Therapeutics (NASDAQ:

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Karyopharm Therapeutics Inc. - Common Stock (NQ:KPTI)

All News about Karyopharm Therapeutics Inc. - Common Stock

Sections

Services

Contact Information

Follow Us